Yinghui Xu

2.6k total citations · 1 hit paper
91 papers, 1.8k citations indexed

About

Yinghui Xu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Yinghui Xu has authored 91 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 36 papers in Pulmonary and Respiratory Medicine and 15 papers in Molecular Biology. Recurrent topics in Yinghui Xu's work include Colorectal Cancer Screening and Detection (18 papers), Lung Cancer Treatments and Mutations (17 papers) and Gastric Cancer Management and Outcomes (12 papers). Yinghui Xu is often cited by papers focused on Colorectal Cancer Screening and Detection (18 papers), Lung Cancer Treatments and Mutations (17 papers) and Gastric Cancer Management and Outcomes (12 papers). Yinghui Xu collaborates with scholars based in United States, China and Australia. Yinghui Xu's co-authors include Kewei Ma, Jeanette M. Daly, Shi Qiu, Ye Guo, Barcey T. Levy, Chao Sun, Xu Wang, Barry L. Carter, John Ely and Arthur J. Hartz and has published in prestigious journals such as Annals of Internal Medicine, The FASEB Journal and Annals of Oncology.

In The Last Decade

Yinghui Xu

84 papers receiving 1.7k citations

Hit Papers

A systematic review of asymptomatic infections with COVID-19 2020 2026 2022 2024 2020 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A systematic review of asymptomatic infections with COVID-19
    2020 608 citations Yinghui Xu, Chao Sun et al. Journal of Microbiology Immunology and Infection profile →

Peers

Yinghui Xu
Thomas Delate United States
Antoni Sisó‐Almirall Spain
Sergio García‐Blas Spain
Beth Nordstrom United States
Gregory S. Calip United States
Clara Bonanad Spain
Belchin Kostov Spain
Arjun Gupta United States
Ritesh Gupta India
Ronald Chow Canada
Thomas Delate United States
Yinghui Xu
Citations per year, relative to Yinghui Xu Yinghui Xu (= 1×) peers Thomas Delate

Countries citing papers authored by Yinghui Xu

Since Specialization
Citations

This map shows the geographic impact of Yinghui Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yinghui Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yinghui Xu more than expected).

Fields of papers citing papers by Yinghui Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yinghui Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yinghui Xu. The network helps show where Yinghui Xu may publish in the future.

Co-authorship network of co-authors of Yinghui Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yinghui Xu. A scholar is included among the top collaborators of Yinghui Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yinghui Xu. Yinghui Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xiaoning, et al.. (2024). Lung enteric-type adenocarcinoma with gastric metastasis: a rare case report and literature review. Frontiers in Immunology. 15. 1486214–1486214. 1 indexed citations
2.
Qiu, Shi, Yinghui Xu, Chao Sun, et al.. (2024). Small cell lung cancer with dermatomyositis: a case report. Frontiers in Oncology. 14. 1325991–1325991.
3.
4.
5.
Xu, Yinghui, Xu Wang, Chao Sun, et al.. (2022). A phase II study of antiangiogenic therapy (Apatinib) plus chemotherapy as second‐line treatment in advanced small cell lung cancer. Cancer Medicine. 12(3). 2979–2989. 5 indexed citations
6.
7.
Xu, Yinghui, Zhiguang Yang, Yunpeng Liu, et al.. (2021). Coexistence of atypical adenomatous hyperplasia, minimally invasive adenocarcinoma and invasive adenocarcinoma: Gene mutation analysis. Thoracic Cancer. 12(5). 693–698. 2 indexed citations
8.
Sun, Mengyao, Ye Guo, Xu Wang, et al.. (2020). Long-term response to second-line afatinib treatment for advanced squamous cell carcinoma non-small cell lung cancer: a rare case report. Journal of International Medical Research. 48(10). 1220764252–1220764252. 1 indexed citations
9.
Xu, Yinghui, Xu Wang, Yunpeng Liu, et al.. (2020). Whole exome sequencing of lung adenocarcinoma and lung squamous cell carcinoma in one individual: A case report. Thoracic Cancer. 11(8). 2361–2364. 3 indexed citations
10.
Cai, Yangyang, Yizhuo Wang, Jingnan Sun, et al.. (2020). Successful treatment of a patient with NSCLC carrying uncommon compound EGFR G719X and S768I mutations using osimertinib: A case report. Journal of International Medical Research. 48(6). 1220728345–1220728345. 7 indexed citations
11.
Xu, Yinghui, Chao Sun, Xu Wang, et al.. (2020). A systematic review of asymptomatic infections with COVID-19. Journal of Microbiology Immunology and Infection. 54(1). 12–16. 608 indexed citations breakdown →
12.
Sun, Mengyao, Yinghui Xu, Xu Wang, et al.. (2020). Follow‐up of an occult tuberculosis scar cancer after resection of metastatic lesions. Thoracic Cancer. 11(8). 2347–2350.
13.
Xu, Yinghui, Hua He, Li Zhang, et al.. (2020). A potentially effective treatment for COVID-19: A systematic review and meta-analysis of convalescent plasma therapy in treating severe infectious disease. International Journal of Infectious Diseases. 98. 334–346. 44 indexed citations
14.
Sun, Mengyao, Ye Guo, Guoguang Shao, et al.. (2019). Analysis of real-word mutations of lung cancer driver genes in five regions of China. Translational Cancer Research. 8(7). 2581–2592. 2 indexed citations
15.
Sun, Mengyao, Ye Guo, Guoguang Shao, et al.. (2019). Analysis of real-word mutations of lung cancer driver genes in five regions of China. Translational Cancer Research. 8(7). 2581–2592. 3 indexed citations
16.
Wang, Xiaomeng, Hongliang Liu, Yinghui Xu, et al.. (2018). Genetic variants in the calcium signaling pathway genes are associated with cutaneous melanoma-specific survival. Carcinogenesis. 40(2). 279–288. 7 indexed citations
17.
Carter, Barry L., et al.. (2017). Selection bias and subject refusal in a cluster-randomized controlled trial. BMC Medical Research Methodology. 17(1). 15 indexed citations
18.
Li, Hui, Shanglei Ning, Yinghui Xu, et al.. (2017). Switching of the substrate specificity of protein tyrosine phosphatase N12 by cyclin‐dependent kinase 2 phosphorylation orchestrating 2 oncogenic pathways. The FASEB Journal. 32(1). 73–82. 10 indexed citations
19.
Yang, Li, et al.. (2011). A Functional Polymorphism in the Epidermal Growth Factor Gene Is Associated with Risk for Glioma in a Chinese Population. Genetic Testing and Molecular Biomarkers. 16(5). 449–452. 9 indexed citations
20.
Weber, Cynthia, et al.. (2008). Reduction in Adverse Symptoms as Blood Pressure Becomes Controlled. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(9). 1104–1114. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Delate Breakdown of academic impact, for papers by Antoni Sisó‐Almirall Breakdown of academic impact, for papers by Sergio García‐Blas Breakdown of academic impact, for papers by Beth Nordstrom Breakdown of academic impact, for papers by Gregory S. Calip Breakdown of academic impact, for papers by Clara Bonanad Breakdown of academic impact, for papers by Belchin Kostov Breakdown of academic impact, for papers by Arjun Gupta Breakdown of academic impact, for papers by Ritesh Gupta Breakdown of academic impact, for papers by Ronald Chow
Rankless by CCL
2026